About

Voriconazole is a broad-spectrum triazole antifungal agent used for the treatment of serious fungal infections. It exerts its fungicidal and fungistatic effects by inhibiting fungal cytochrome P450-dependent 14-alpha-demethylase, an enzyme crucial for the biosynthesis of ergosterol. Ergosterol is a vital component of the fungal cell membrane, and its depletion leads to increased cell membrane permeability, leakage of cellular contents, and ultimately, fungal cell death. This mechanism makes voriconazole effective against a wide range of pathogenic fungi, including Candida species (including fluconazole-resistant strains), Aspergillus species, and certain other rare molds and yeasts.

Its pharmacokinetic profile allows for both oral and intravenous administration, providing flexibility in managing severe systemic fungal infections. Voriconazole is particularly important in immunocompromised patients, such as those undergoing chemotherapy, organ transplantation, or with HIV/AIDS, where invasive fungal infections can be life-threatening. Therapeutic drug monitoring is often recommended due to its variable pharmacokinetics and potential for drug interactions.

Uses

Treatment of invasive aspergillosis.
Treatment of candidemia in non-neutropenic patients.
Treatment of serious fungal infections caused by Scedosporium apiospermum and Fusarium species.
Prophylaxis of invasive fungal infections in high-risk patients.

Directions For Use

Take orally, preferably one hour before or one hour after a meal. Follow your doctor's prescribed dosage and schedule.

Benefits

Broad-spectrum antifungal activity.
Effective against resistant Candida strains.
Available in both oral and intravenous forms.
Crucial for immunocompromised patients.
Penetrates central nervous system.
Improved survival rates in severe infections.

Side Effects

Visual disturbances (blurred vision, altered color perception)
Fever
Nausea
Vomiting
Diarrhea
Headache
Rash
Abnormal liver function tests
Peripheral edema
Hallucinations
Photosensitivity
Hypokalemia

Safety Measures

Alcohol - Avoid alcohol as it can increase the risk of liver toxicity and interact with voriconazole metabolism.
Pregnancy - Contraindicated in pregnancy due to potential for fetal harm; use effective contraception during treatment.
Breastfeeding - Not recommended during breastfeeding as it may pass into breast milk and harm the infant.
Liver - Use with caution in patients with pre-existing liver impairment; dose adjustment and close monitoring of liver function are essential.
Kidney - Oral formulation is generally safe; intravenous formulation contains cyclodextrin, which can accumulate in severe renal impairment.
Lung - No specific contraindications; however, some patients may experience respiratory side effects, though rare.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.

Shipping & Location